SlideShare a Scribd company logo
Amblyopia
Treatment Studies
Pediatric Eye Disease Investigator Group
2002-2018
(Based on Publications as of September 2018)
Alvina Pauline D. Santiago, MD
September 2018
#PEDIG (c) APSantiago 2018
http://pedig.jaeb.org/Studies.aspx
http://www.abcd-vision.org/amblyopia/ats-pedig.html
#PEDIG(c) APSantiago 2018
http://talleyeyecare.com
Amblyopia Definition
Gunter K von Noorden
• Unilateral or bilateral decrease in
VA
• caused by pattern vision
deprivation (lack of adequate
vision stimulation) or abnormal
binocular interaction
• no cause can be detected by
physical examination
• reversible by therapeutic
measures
http://www.ascrs.org
vonNoorden GK. Amblyopia. A Multidisciplinary Approach.
Proctor Lecture. IOVS; 1985; 26: 1704-16
#PEDIG
(c) APSantiago 2018
Definition of Terms: PEDIG
•Amblyopia
• Mild: 20/25 to < 20/40
• Moderate: 20/40 to 20/100 ATS-1, -8, -9
20/40 to 20/80 ATS-2B, -4, 10
• Severe: 20/100 to 20/400 ATS-2A
#PEDIG (c) APSantiago 2018
Amblyopia Treatment Study-1 (ATS-01)
Atropine vs part-time patch, moderate amblyopia
I. Arch Ophthalmol 2002: 120(3) 268-278
II. Arch Ophthalmol 2002: 120 (3) 281-287
III. Arch Ophthalmol 2003: 121 (11): 1625-32
IV. Arch Ophthalmol 2005: 123 (2): 149-157
V. J AAPOS 2005: 9 (6): 542-545
VI. Arch Ophthalmol 2008: 1039-1044
VII. JAMA Ophthalmol. 2014 July ; 132(7): 799–805
VIII. Arch Ophthalmol 2002: 120(3) 268-278
#PEDIG (c) APSantiago 2018
Amblyopia Treatment Study-1 (ATS-01)
Atropine vs part-time patch, moderate amblyopia
 3-7 years
 >/= 3 lines 79%P, 74%A
 Atropine better acceptability
 Strabismic=anisometropic amblyopia
 2 yr follow-up, after 6 months treatment,
both 2 lines behind
 Same rates of deterioration &
improvement
 New strabismus resolved with cessation
of treatment (18%P, 16%A)
#PEDIG (c) APSantiago 2018
10 & 15 years follow-up
• improvement maintained
• residual amblyopia common
http://www.ibeta.com
Arch Ophthalmol 2008: 1039-1044;
JAMA Ophthalmol. 2014 July ; 132(7): 799–805
Amblyopia Treatment Study-1 (ATS-01)
Atropine vs part-time patch, moderate amblyopia
http://logopond.com/
#PEDIG (c) APSantiago 2018
Amblyopia Treatment Study-2 (ATS-2)
(6h vs full; 2h vs 6h)
• I. Ophthalmology 2003: 110(11) 2075-2087
• II. Arch Ophthalmol 2003: 121 (5) 603-611
• III. J AAPOS 2004: 8(5): 420-428
https://upload.wikimedia.org
https://www.hosteurope.de https://blog.logos.com
#PEDIG (c) APSantiago 2018
Amblyopia Treatment Study-2A (ATS-2A)
Patch 6 hrs vs full time, severe amblyopia
• Full time: all waking hrs minus 1 hour off
• Severe amblyopia: 20/100-20/400
• Age 3-7 years
• After 4 months
• 4.8 lines in 6 hrs group; vs 4.7 in full time
http://oceansignal.com
http://oceansignal.com
Ophthalmology 2003: 110(11) 2075-2087
#PEDIG (c) APSantiago 2018
Amblyopia Treatment Study-2B (ATS-2B)
Patch 2 hrs (minimal time) vs 6 hrs (part time) for Moderate amblyopia
• moderate: 20/40-20/80
• ages 3-7 years
• At 4 months: 2.4 lines in both groups with 1 hr of
near visual activity
https://www.hosteurope.de
https://upload.wikimedia.org
http://oceansignal.com
Arch Ophthalmol 2003: 121 (5) 603-611
#PEDIG
(c) APSantiago 2018
Amblyopia Treatment Study-2C (ATS-2C)
Recurrence after cessation of patching / Atropine
• younger than age 8
• 3 months of amblyopia treatment
• Recurrence same
• 24% of patched patients;
• 21% of atropinized
• 1/4 experience recurrence within
1st year of cessation
• RCT for weaning vs. no-weaning
J AAPOS 2004: 8(5): 420-428
#PEDIG (c) APSantiago 2018
Amblyopia Treatment Study-3 (ATS-3)
7 to < 18: spectacles vs atropine/patch
• Arch Ophthalmol 2005: 123: 437-477 (Control)
• Am J Ophthalmol 2004: 137: 581-583 (10-18yrs)
• Arch Ophthalmol 2007: 125: 655-659
http://cdn4.teen.com
http://cdn4.teen.com
#PEDIG (c) APSantiago 2018
Amblyopia Treatment Study-3 (ATS-3)
7 to < 18: spectacles vs atropine/patch
• ages 7-17 years
• 20/40-20/400
• Given optimal optical
correction then randomized
• Tx: glasses, patch plus near
activity, atropine
• No Tx: glasses alone
http://cdn4.teen.com
Arch Ophthalmol 2005: 123: 437-477 (Control)
Am J Ophthalmol 2004: 137: 581-583 (10-18yrs)
Arch Ophthalmol 2007: 125: 655-659
#PEDIG (c) APSantiago 2018
Amblyopia Treatment Study-3 (ATS-3)
7 to < 18: spectacles vs atropine/patch
• Responders: improved > 10 letters / 2 lines
• Improves with glasses alone in 25%
• Most patients left with residual VA deficit
• Ages 7-12: tx improved amblyopia even if previously
treated
• Ages 13-17: tx improved if no previous tx for
amblyopia
• Unknown: if treatment results robust http://cdn4.teen.com
Arch Ophthalmol 2005: 123: 437-477 (Control)
Am J Ophthalmol 2004: 137: 581-583 (10-18yrs)
Arch Ophthalmol 2007: 125: 655-659
#PEDIG (c) APSantiago 2018
Amblyopia Treatment Study-4 (ATS-4)
Atropine weekend vs daily; moderate amblyopia
• 20/40-20/80
• ages 3-7 years
• Similar results with
weekend atropine vs daily
atropine
• 2.3 lines in both groups
https://thejobshop.files.wordpress.com
Ophthalmology 2004: 111: 2076-2085
#PEDIG (c) APSantiago 2018
Amblyopia Treatment Study-5 (ATS-5)
3 to < 7y, spectacles alone
• amblyopia improved with glasses by
> 2 lines in 77%
• amblyopia resolved in 27% with
glasses alone
• 3 line improvement average
• Lessen the burden of amblyopia
therapy
Ophthalmology 2006: 113 (6) 895-903.
#PEDIG (c) APSantiago 2018
Amblyopia Treatment Study-5 (ATS-5)
spectacles first then patch 2 hrs vs spectacles, 20/40-20/400
o Strabismic &anisometropic amblyopia
o 2 hrs (1 hr near activity) + specs vs. specs alone
• At 5 wks: 1.1 lines improvement for treated; 0.5 lines for
specs alone
• Any visit average: 2.2 lines treated; 1.1 lines specs
• After glasses, 2 hrs patching (with 1 hr near activity)
improves moderate to severe amblyopia
https://t2.ftcdn.net
✚
http://cdn4.teen.com
#PEDIG (c) APSantiago 2018
http://cdn4.teen.com
Amblyopia Treatment Study-6 (ATS-6)
3 to <7, patch 2 hrs with near vs far activities after spectacles
• Pilot: 4 wks: suggestion of
greater improvement in
amblyopic eye with near
activities prescribed
• 2.6 lines near; 1.6 lines far (p=0.07)
http://www.adventuresetup.com
http://glacialblog.com
J AAPOS 2005: 9: 129-136
#PEDIG (c) APSantiago 2018
Amblyopia Treatment Study-6 (ATS-6)
3 to <7, patch 2 hrs with near vs far activities after spectacles
(VA 20/40 to 20/400)
• At 8 wks: improvement in
amblyopic eye
• Distance activity: 2.6 lines
• Near activity: 2.5 lines 2.6 lines
near; 1.6 lines far (p=0.07)
• Similar for both groups, even at 2,
5, 17 wks.
http://s7.photobucket.com
Ophthalmology 2008; 115: 2071-78
#PEDIG (c) APSantiago 2018
Amblyopia Treatment Study-6 (ATS-6)
3 to <7, patch 2 hrs with near vs far activities after spectacles
(VA 20/40 to 20/400)
• 3.6 lines improvement in severe amblyopic
group
• Adding near activities did not improve VA
outcome in anisometropic, strabismic,
combined amblyopia with 2 hrs of daily
patching
• Severe amblyopia can respond even to 2 hrs of
daily patching
http://www.getbettergradesnow.com
Ophthalmology 2008; 115: 2071-78
#PEDIG (c) APSantiago 2018
Amblyopia Treatment Study-7 (ATS-7)
Bilateral refractive amblyopia 20/40-20/400; specs x 1 yr
(Response to treatment of previously untreated presumed
bilateral refractive amblyopia)
• less than 10 years old
• Hypermetropia > 4.0D;
• astigmatism > 2.0D
• Eyeglasses alone improves
binocular VA to 20/25 or better
within 1 year
http://cdn4.teen.com
Am J Ophthalmol 2007: 144: 487-496
#PEDIG (c) APSantiago 2018
• Age 7-12; moderate amblyopia
20/40-20/100
• similar degrees of improvement
• About 1 in 5 achieved VA of 20/25 or
better in the amblyopic eye.
• Atropine and patching achieved
similar results among older children
with unilateral amblyopia
Amblyopia Treatment Study-9 (ATS-9)
(7 to <13, ATS-1: weekend atropine vs. patch 2hours
http://dissurat.net
https://t2.ftcdn.net
Arch Ophthalmol. 2008;126(12):1634-1642
#PEDIG (c) APSantiago 2018
Amblyopia Treatment Study-10 (ATS-10)
Bangerter filters vs. patching
• moderate amblyopia 20/40-20/80; 3-<10y.
• At 24 wks, 1.9 lines improvement with Bangerter,
vs.2.3 lines in patching group
• Average difference in vision improvement between
Bangerter filters and patching was less than half a
line
• ower burden of treatment on the child and family,
Bangerter filter treatment is a reasonable option
to consider for initial treatment of moderate
amblyopia.
Ophthalmology 2010;117:998-1004. |
#PEDIG (c) APSantiago 2018 23
ATS 13: An Observational Study of Optical
Correction for Strabismic & Combined
Strabismic Anisometropic Amblyopia in
Children 3 to < 7 years old
• VA after 18 weeks improved mean of 2.6 lines
• 75% > 2 lines, 54% > 3 lines
• Resolution of amblyopia in 32%
• Greater in Strabismic Amblyopia alone
(3.2 vs 2.3 lines)
• VA improved regardless of whether alignment
better
• Optical treatment alone results in clinically meaningful
improvement;
• may consider as primary sole initial treatment
Ophthalmology 2012; 119: 150-158. Epub 2011 Sep 29.
#PEDIG (c) APSantiago 2018
ATS 15: Increasing patching for amblyopia study
from 2 to 6 hours
(3 to <8, 20/50 to 20/400)
• When amblyopic eye VA stops improving with 2 hours of
daily patching, increasing the daily patching dosage to 6
hours results in more improvement in VA after 10 weeks
compared with continuing 2 hours daily.
Pediatric Eye Disease Investigator Group. A randomized trial of increasing patching for amblyopia.
Ophthalmology 2013 Nov;120(11):2270-7. Epub 2013 Jun 4
#PEDIG (c) APSantiago 2018
Amblyopia Treatment Study-17 (ATS-
17)
Levodopa for Residual Amblyopia
• 7-12y, 20/50 to 20/400 with patching
• 139 children 7-12 years old
• Strabismic &/or anisometropic amblyopia
• Pilot showed improvement at 4 weeks
• But study at 18 weeks: placebo = levodopa
Ophthalmology. 2015 May;122(5):874-819
Repka MX, Kraker RT, Beck RW, et. al., Pediatric Eye Disease Investigator Group. Pilot study of levodopa dose as treatment for
residual amblyopia in children aged 8 years to younger than 18 years. Arch Ophthalmol 2010;128(9):1215-7.
#PEDIG (c) APSantiago 2018
What more PEDIG?
http://www.imore.com
http://www.geek.com
http://www.cclonline.com/
http://icons.iconarchive.com
#PEDIG (c) APSantiago 2018
Amblyopia Treatment Study-18 (ATS-18)
Binocular Computer Studies for Amblyopia
Ended May 2016
• To compare the effectiveness of 1 hour/day of binocular
game play 7 days per week (minimum of 4 days per week)
with 2 hours/day of patching 7 days per week, in children 5
to <13 years of age (younger cohort), as a non-inferiority
study.
• To compare the effectiveness of 1 hour/day of binocular
game play 7 days per week (minimum of 4 days per week)
with 2 hours/day of patching 7 days per week, in children
13 to <17 years of age (older cohort), as a superiority study.
#PEDIG (c) APSantiago 2018
Amblyopia Treatment Study-18 (ATS-18)
Binocular iPAD game vs patching (5-12)
• Non inferiority RCT
• 16 wk trial
• iPAD improved 1.05 lines vs patching 1.35 lines
• primary noninferiority analysis was indeterminate
• a post hoc analysis suggested that VA improvement with iPad not as
good as with 2 hours of prescribed daily patching.
Holmes et al … PEDIG. Effect of a binocular iPad game versus part-time
patching in children aged 5 to 12 with amblyopia: a randomized clinical
trial. JAMA Ophthalmol 2016;134(12)
#PEDIG (c) APSantiago 2018
Amblyopia Treatment Study-18 (ATS-18)
Binocular iPAD game vs patching (13 to <17)
• Amblyopia 20/40 to 20/200
• 16 wks of iPAD 1 h game or patching 2h/day
• 3.5 letters in iPAD group vs. 6.5 letters in patching group
• Even in the iPAD group, only 13% of patients completed >75% of
prescribed treatment
• PATCHING still better, iPAD possibly worse
• Compliance vs lack of treatment effect?
Manh VM, Holmes JM, Lazar EL, et al and Pediatric Eye Disease Investigator Group. A
Randomized Trial Of A Binocular iPad Game Versus Part-Time Patching In Children 13
To 16 Years Of Age With Amblyopia. Am J Ophthalmol 2018;186:104-15.
#PEDIG (c) APSantiago 2018
Non PEDIG RCTs
https://www.aao.org
#PEDIG (c) APSantiago 2018
Non PEDIG RCTs
https://www.aao.org
• 3-8 y, 20/40 to 20/100
• Glasses x 12 wks, no improvement
• Occluded 50% x 4h vs Patching 2h
• Not inferior to patching
• Alternative for treatment
#PEDIG (c) APSantiago 2018
Amblyopia Treatment Study-19 (ATS-19)
Excimer Laser Surgery for Anisometropic Amblyopia
• Upcoming
• To compare the efficacy and safety of surgical
treatment (PRK) versus non-surgical treatment
of anisometropic amblyopia in children who
have failed conventional treatment due to non-
compliance or non-response.
#PEDIG (c) APSantiago 2018
Amblyopia Treatment Study-20 (ATS-20)
Binocular Dig Rush Game for Amblyopia
• Recruiting
• 1 hour/day of binocular game play 5 days per
week plus spectacle correction vs. spectacle
correction only
• for treatment of amblyopia
• children 4 to <13 years of age.
#PEDIG (c) APSantiago 2018
https://www.ophth.wisc.edu/blog/2018/02/12/binocular-dig-
rush-game-treatment-amblyopia/
Recap: Lessons learned from PEDIG
1. Atropine = patching
• 3-7 years old, 20-40 to 20/100
• Anisometropic and strabismic amblyopia
• Long-term follow-up 10y and 15y same
• New strabismus can develop in either by 2
years 16-18%,
• Resolved at cessation of therapy
• Residual amblyopia common
• 7-12y, 20/40 to 20/100
• 1 in 5 achieved > 20/25
#PEDIG (c) APSantiago 2018
Recap: Lessons learned from PEDIG
2. 6 hours = full time
• 3-7 years old
• Severe amblyopia 20/100-20/400
3. 2 = 6 hours
• 3-7 years old
• Moderate amblyopia 20/40 to 20/80
#PEDIG (c) APSantiago 2018
Recap: Lessons learned from PEDIG
4. Amblyopia improves with glasses alone.
• 20/40 to 20/400, 7-17y (25%)
• 3 to <7, 20/40 to 20/400
• Resolved in 27%
• Improved in 77%
• Better improvement in strabismic than
combined strabismic and amblyopic
amblyopia
• Less than 10y, 20/40 to 20/400
• Bilateral refractive amblyopia VA > 20/25 in
a year
AP Santiago MD 2017
#PEDIG (c) APSantiago 2018
Recap: Lessons learned from PEDIG
5. Atropine and/or patching can be added
after glasses.
• Moderate to severe amblyopia 20/40 to
20/400, 7 to <18
6. Add patching after glasses given time to
work.
• Moderate to severe amblyopia: 20/40 to 20/400
• 3 to <7y, 2h patch (1 hr near)
• 7-12 even if previously treated
• 13 to <18 if no previous treatment
#PEDIG (c) APSantiago 2018
Recap: Lessons learned from PEDIG
7. Daily = weekly atropine
• 3-7 years
• Moderate amblyopia: 20/40 to 20/80
8. Near = Far
• 3-7 years
• moderate to severe amblyopia: 20/40 to
20/400
AP Santiago MD 2017
#PEDIG (c) APSantiago 2018
Lessons learned from PEDIG Studies
9. Severe amblyopia can improve even with 2 h of
patching
• 3-7 years, 20/40 to 20/400
10.Bangerter filter a reasonable option.
• 3 to <10, 20/40 to 20/80
• Not better than patching
• More acceptable
11.Patching 2h/d better than binocular iPAD
• 5-<13, 13 to <17
• 20/40 to 20/200
#PEDIG (c) APSantiago 2018
Lessons learned from PEDIG Studies
12. Intensive final push with atropine and patch not
effective.
13.Levodopa same as placebo.
• 8-17y, already on patching
14.6h >2h: Increasing 2 to 6 hours can improve
amblyopia
• 3 to <8m 20/50 to 20/400
• if plateau with 2 hours reached
15.Plano lenses don’t work.
16.Standardizing vision therapy unsuccessful.
#PEDIG (c) APSantiago 2018
What the future holds
• Laser refractive correction as a viable option for
anisometropic amblyopia
• Others options
• Virtual reality games
• Smart glasses
• Dichoptic movie viewing
AP Santiago MD 2017
#PEDIG (c) APSantiago 2018
Virtual Reality Games for Amblyopia
❖ 0:33 The Oculus Rift
❖ 0.38 – 1:29 How it Works
https://www.youtube.com/watch?v=KumScsJ0xNQ
#PEDIG (c) APSantiago 2018
Amblyopia Glasses
VIDI SMART GLASSES AMBLYZ AMBLYOPIA GLASSES
http://eyepatch.com.au/product/Vidi-Smart-Glasses
https://www.aao.org
#PEDIG (c) APSantiago 2018
Every closed eye is not sleeping, and every open eye is not seeing.
-- Bill Cosby
#PEDIG(c) APSantiago 2018

More Related Content

What's hot

OPTOMETRY CASE ANALYSIS (PEDIATRIC PATIENT)
OPTOMETRY CASE ANALYSIS (PEDIATRIC PATIENT) OPTOMETRY CASE ANALYSIS (PEDIATRIC PATIENT)
OPTOMETRY CASE ANALYSIS (PEDIATRIC PATIENT)
ANNERA LEA BANUS
 
Hfa
HfaHfa
2016 Amblyopia PEDIG Studies
2016 Amblyopia PEDIG Studies2016 Amblyopia PEDIG Studies
2016 Amblyopia PEDIG Studies
Alvina Pauline Santiago, MD
 
Glaucoma suspects and normal pressure glaucoma
Glaucoma suspects and normal pressure glaucomaGlaucoma suspects and normal pressure glaucoma
Glaucoma suspects and normal pressure glaucoma
Burdwan Medical College and Hospital
 
Orthokeratology power point presentation
Orthokeratology power point presentationOrthokeratology power point presentation
Orthokeratology power point presentationDigital-Marketing-Guru
 
Gonioscopy
GonioscopyGonioscopy
Gonioscopy
DrYashasGoyal
 
Refraction and Retinoscopy
Refraction and RetinoscopyRefraction and Retinoscopy
Refraction and Retinoscopy
Dr. Agarwal's Group of Eye Hospital
 
Hess chart
Hess chartHess chart
Hess chart
Jagdish Dukre
 
Prescribing eyeglasses for children revisited 2015 v2
Prescribing eyeglasses for children revisited 2015 v2Prescribing eyeglasses for children revisited 2015 v2
Prescribing eyeglasses for children revisited 2015 v2
Alvina Pauline Santiago, MD
 
prescribing glasses for pediatric population
 prescribing glasses for pediatric population  prescribing glasses for pediatric population
prescribing glasses for pediatric population
JenishaBhattarai2
 
Sensory evaluation of squint
Sensory  evaluation of squintSensory  evaluation of squint
Sensory evaluation of squint
Dr Laltanpuia Chhangte
 
anomalous retinal correspondence
anomalous retinal correspondenceanomalous retinal correspondence
anomalous retinal correspondence
Rajeshwori
 
Real pediatric refraction and spectacle power prescription in pediatrics.
Real pediatric refraction and spectacle power prescription in pediatrics.Real pediatric refraction and spectacle power prescription in pediatrics.
Real pediatric refraction and spectacle power prescription in pediatrics.
Bipin Koirala
 
Double elevator palsy
Double  elevator  palsyDouble  elevator  palsy
Double elevator palsy
Vinitkumar MJ
 
Armd cases in low vision
Armd cases in low visionArmd cases in low vision
Armd cases in low vision
Jasmin Modi
 
2019 Prescribing Eyeglasses in Children
2019 Prescribing Eyeglasses in Children2019 Prescribing Eyeglasses in Children
2019 Prescribing Eyeglasses in Children
Alvina Pauline Santiago, MD
 
Case Presentation: Duane's Syndrome
Case Presentation: Duane's SyndromeCase Presentation: Duane's Syndrome
Case Presentation: Duane's Syndrome
Anis Suzanna Mohamad
 
Evaluation of squint - The Basics
Evaluation of squint - The BasicsEvaluation of squint - The Basics
Evaluation of squint - The Basics
drindeevarmishra
 

What's hot (20)

OPTOMETRY CASE ANALYSIS (PEDIATRIC PATIENT)
OPTOMETRY CASE ANALYSIS (PEDIATRIC PATIENT) OPTOMETRY CASE ANALYSIS (PEDIATRIC PATIENT)
OPTOMETRY CASE ANALYSIS (PEDIATRIC PATIENT)
 
Hfa
HfaHfa
Hfa
 
2016 Amblyopia PEDIG Studies
2016 Amblyopia PEDIG Studies2016 Amblyopia PEDIG Studies
2016 Amblyopia PEDIG Studies
 
Glaucoma suspects and normal pressure glaucoma
Glaucoma suspects and normal pressure glaucomaGlaucoma suspects and normal pressure glaucoma
Glaucoma suspects and normal pressure glaucoma
 
Prism in ophthalmology
Prism in ophthalmologyPrism in ophthalmology
Prism in ophthalmology
 
Orthokeratology power point presentation
Orthokeratology power point presentationOrthokeratology power point presentation
Orthokeratology power point presentation
 
Gonioscopy
GonioscopyGonioscopy
Gonioscopy
 
Refraction and Retinoscopy
Refraction and RetinoscopyRefraction and Retinoscopy
Refraction and Retinoscopy
 
Hess chart
Hess chartHess chart
Hess chart
 
Prescribing eyeglasses for children revisited 2015 v2
Prescribing eyeglasses for children revisited 2015 v2Prescribing eyeglasses for children revisited 2015 v2
Prescribing eyeglasses for children revisited 2015 v2
 
prescribing glasses for pediatric population
 prescribing glasses for pediatric population  prescribing glasses for pediatric population
prescribing glasses for pediatric population
 
Sensory evaluation of squint
Sensory  evaluation of squintSensory  evaluation of squint
Sensory evaluation of squint
 
anomalous retinal correspondence
anomalous retinal correspondenceanomalous retinal correspondence
anomalous retinal correspondence
 
Real pediatric refraction and spectacle power prescription in pediatrics.
Real pediatric refraction and spectacle power prescription in pediatrics.Real pediatric refraction and spectacle power prescription in pediatrics.
Real pediatric refraction and spectacle power prescription in pediatrics.
 
Double elevator palsy
Double  elevator  palsyDouble  elevator  palsy
Double elevator palsy
 
Armd cases in low vision
Armd cases in low visionArmd cases in low vision
Armd cases in low vision
 
Biometry
BiometryBiometry
Biometry
 
2019 Prescribing Eyeglasses in Children
2019 Prescribing Eyeglasses in Children2019 Prescribing Eyeglasses in Children
2019 Prescribing Eyeglasses in Children
 
Case Presentation: Duane's Syndrome
Case Presentation: Duane's SyndromeCase Presentation: Duane's Syndrome
Case Presentation: Duane's Syndrome
 
Evaluation of squint - The Basics
Evaluation of squint - The BasicsEvaluation of squint - The Basics
Evaluation of squint - The Basics
 

Similar to 2018 pedig amblyopia v1

Amblyopia treatment study (ATS) for children
Amblyopia treatment study (ATS) for childrenAmblyopia treatment study (ATS) for children
Amblyopia treatment study (ATS) for children
RashtriyaSamajseviPa
 
AMBLYOPIA TREATMENT STUDIES
AMBLYOPIA TREATMENT STUDIESAMBLYOPIA TREATMENT STUDIES
AMBLYOPIA TREATMENT STUDIES
SSSIHMS-PG
 
Passive Therapy in Management of Amblyopia (healthkura.com)
Passive Therapy in Management of Amblyopia (healthkura.com)Passive Therapy in Management of Amblyopia (healthkura.com)
Passive Therapy in Management of Amblyopia (healthkura.com)
Bikash Sapkota
 
2018 Pediatric Cataract Surgery: Pearls for the Non Pediatric Ophthalmologist
2018 Pediatric Cataract Surgery: Pearls for the Non Pediatric Ophthalmologist2018 Pediatric Cataract Surgery: Pearls for the Non Pediatric Ophthalmologist
2018 Pediatric Cataract Surgery: Pearls for the Non Pediatric Ophthalmologist
Alvina Pauline Santiago, MD
 
Diabetic retinopathy ranibizumab : A disease modifying therapy
Diabetic retinopathy ranibizumab : A disease modifying therapyDiabetic retinopathy ranibizumab : A disease modifying therapy
Diabetic retinopathy ranibizumab : A disease modifying therapy
drsomduttprasad
 
Updates from AMD clinical trials
Updates from AMD clinical trialsUpdates from AMD clinical trials
Updates from AMD clinical trials
Yasuo Yanagi
 
Eyeglass prescribing in children 2024 SLMC.pdf
Eyeglass prescribing in children 2024 SLMC.pdfEyeglass prescribing in children 2024 SLMC.pdf
Eyeglass prescribing in children 2024 SLMC.pdf
Alvina Pauline Santiago, MD
 
Consideration of Binocular Parameters in Spectacle Correction of Anisometropi...
Consideration of Binocular Parameters in Spectacle Correction of Anisometropi...Consideration of Binocular Parameters in Spectacle Correction of Anisometropi...
Consideration of Binocular Parameters in Spectacle Correction of Anisometropi...Yasmine Abdulrahman
 
Dr Somdutt Prasad on Current Management of DME: Learning from Protocol T2 Res...
Dr Somdutt Prasad on Current Management of DME: Learning from Protocol T2 Res...Dr Somdutt Prasad on Current Management of DME: Learning from Protocol T2 Res...
Dr Somdutt Prasad on Current Management of DME: Learning from Protocol T2 Res...
drsomduttprasad
 
Should Astigmatism be Corrected until the Age of Three? Results of a Six-year...
Should Astigmatism be Corrected until the Age of Three? Results of a Six-year...Should Astigmatism be Corrected until the Age of Three? Results of a Six-year...
Should Astigmatism be Corrected until the Age of Three? Results of a Six-year...
inventionjournals
 
Ophthal Studies & Trials
Ophthal Studies & TrialsOphthal Studies & Trials
Ophthal Studies & Trials
Meng Hsien Yong
 
Debate ANTIVEGF CHOICE IN AMD
Debate ANTIVEGF CHOICE IN AMDDebate ANTIVEGF CHOICE IN AMD
Debate ANTIVEGF CHOICE IN AMD
AjayDudani1
 
Preferred Patterns of Myopia Control in the Philippines.pdf
Preferred Patterns of Myopia Control in the Philippines.pdfPreferred Patterns of Myopia Control in the Philippines.pdf
Preferred Patterns of Myopia Control in the Philippines.pdf
Alvina Pauline Santiago, MD
 
Strategies for better toric IOL outcomes (Apr 2018)
Strategies for better toric IOL outcomes (Apr 2018)Strategies for better toric IOL outcomes (Apr 2018)
Strategies for better toric IOL outcomes (Apr 2018)
Han Chieh Yu
 
Irregular Astigmatism after DSAEK
Irregular Astigmatism after DSAEKIrregular Astigmatism after DSAEK
Irregular Astigmatism after DSAEK
Luca Avoni
 
Nuovo IOL TRIFOCALE: caratteristiche tecniche
Nuovo IOL TRIFOCALE: caratteristiche tecnicheNuovo IOL TRIFOCALE: caratteristiche tecniche
Nuovo IOL TRIFOCALE: caratteristiche tecniche
ASMaD
 
Current Trend in Management of Amblyopia (Amblyopia Therapy)/ Amblyopia Treat...
Current Trend in Management of Amblyopia (Amblyopia Therapy)/ Amblyopia Treat...Current Trend in Management of Amblyopia (Amblyopia Therapy)/ Amblyopia Treat...
Current Trend in Management of Amblyopia (Amblyopia Therapy)/ Amblyopia Treat...
Bikash Sapkota
 
Major review of important trial in glaucoma
Major review of important trial in glaucomaMajor review of important trial in glaucoma
Major review of important trial in glaucoma
Panit Cherdchu
 
Whats New in AMD - 2012
Whats New in AMD - 2012Whats New in AMD - 2012
Whats New in AMD - 2012
Rick Trevino
 
Diagnosis & management of accomodative esotropia
Diagnosis & management of accomodative esotropiaDiagnosis & management of accomodative esotropia
Diagnosis & management of accomodative esotropia
Anis Suzanna Mohamad
 

Similar to 2018 pedig amblyopia v1 (20)

Amblyopia treatment study (ATS) for children
Amblyopia treatment study (ATS) for childrenAmblyopia treatment study (ATS) for children
Amblyopia treatment study (ATS) for children
 
AMBLYOPIA TREATMENT STUDIES
AMBLYOPIA TREATMENT STUDIESAMBLYOPIA TREATMENT STUDIES
AMBLYOPIA TREATMENT STUDIES
 
Passive Therapy in Management of Amblyopia (healthkura.com)
Passive Therapy in Management of Amblyopia (healthkura.com)Passive Therapy in Management of Amblyopia (healthkura.com)
Passive Therapy in Management of Amblyopia (healthkura.com)
 
2018 Pediatric Cataract Surgery: Pearls for the Non Pediatric Ophthalmologist
2018 Pediatric Cataract Surgery: Pearls for the Non Pediatric Ophthalmologist2018 Pediatric Cataract Surgery: Pearls for the Non Pediatric Ophthalmologist
2018 Pediatric Cataract Surgery: Pearls for the Non Pediatric Ophthalmologist
 
Diabetic retinopathy ranibizumab : A disease modifying therapy
Diabetic retinopathy ranibizumab : A disease modifying therapyDiabetic retinopathy ranibizumab : A disease modifying therapy
Diabetic retinopathy ranibizumab : A disease modifying therapy
 
Updates from AMD clinical trials
Updates from AMD clinical trialsUpdates from AMD clinical trials
Updates from AMD clinical trials
 
Eyeglass prescribing in children 2024 SLMC.pdf
Eyeglass prescribing in children 2024 SLMC.pdfEyeglass prescribing in children 2024 SLMC.pdf
Eyeglass prescribing in children 2024 SLMC.pdf
 
Consideration of Binocular Parameters in Spectacle Correction of Anisometropi...
Consideration of Binocular Parameters in Spectacle Correction of Anisometropi...Consideration of Binocular Parameters in Spectacle Correction of Anisometropi...
Consideration of Binocular Parameters in Spectacle Correction of Anisometropi...
 
Dr Somdutt Prasad on Current Management of DME: Learning from Protocol T2 Res...
Dr Somdutt Prasad on Current Management of DME: Learning from Protocol T2 Res...Dr Somdutt Prasad on Current Management of DME: Learning from Protocol T2 Res...
Dr Somdutt Prasad on Current Management of DME: Learning from Protocol T2 Res...
 
Should Astigmatism be Corrected until the Age of Three? Results of a Six-year...
Should Astigmatism be Corrected until the Age of Three? Results of a Six-year...Should Astigmatism be Corrected until the Age of Three? Results of a Six-year...
Should Astigmatism be Corrected until the Age of Three? Results of a Six-year...
 
Ophthal Studies & Trials
Ophthal Studies & TrialsOphthal Studies & Trials
Ophthal Studies & Trials
 
Debate ANTIVEGF CHOICE IN AMD
Debate ANTIVEGF CHOICE IN AMDDebate ANTIVEGF CHOICE IN AMD
Debate ANTIVEGF CHOICE IN AMD
 
Preferred Patterns of Myopia Control in the Philippines.pdf
Preferred Patterns of Myopia Control in the Philippines.pdfPreferred Patterns of Myopia Control in the Philippines.pdf
Preferred Patterns of Myopia Control in the Philippines.pdf
 
Strategies for better toric IOL outcomes (Apr 2018)
Strategies for better toric IOL outcomes (Apr 2018)Strategies for better toric IOL outcomes (Apr 2018)
Strategies for better toric IOL outcomes (Apr 2018)
 
Irregular Astigmatism after DSAEK
Irregular Astigmatism after DSAEKIrregular Astigmatism after DSAEK
Irregular Astigmatism after DSAEK
 
Nuovo IOL TRIFOCALE: caratteristiche tecniche
Nuovo IOL TRIFOCALE: caratteristiche tecnicheNuovo IOL TRIFOCALE: caratteristiche tecniche
Nuovo IOL TRIFOCALE: caratteristiche tecniche
 
Current Trend in Management of Amblyopia (Amblyopia Therapy)/ Amblyopia Treat...
Current Trend in Management of Amblyopia (Amblyopia Therapy)/ Amblyopia Treat...Current Trend in Management of Amblyopia (Amblyopia Therapy)/ Amblyopia Treat...
Current Trend in Management of Amblyopia (Amblyopia Therapy)/ Amblyopia Treat...
 
Major review of important trial in glaucoma
Major review of important trial in glaucomaMajor review of important trial in glaucoma
Major review of important trial in glaucoma
 
Whats New in AMD - 2012
Whats New in AMD - 2012Whats New in AMD - 2012
Whats New in AMD - 2012
 
Diagnosis & management of accomodative esotropia
Diagnosis & management of accomodative esotropiaDiagnosis & management of accomodative esotropia
Diagnosis & management of accomodative esotropia
 

More from Alvina Pauline Santiago, MD

Ocular hypotony following reenclavation of a partially dislocated (disenclava...
Ocular hypotony following reenclavation of a partially dislocated (disenclava...Ocular hypotony following reenclavation of a partially dislocated (disenclava...
Ocular hypotony following reenclavation of a partially dislocated (disenclava...
Alvina Pauline Santiago, MD
 
Reenclavation of a partially disenclavated retropupillary iris-clipped intrao...
Reenclavation of a partially disenclavated retropupillary iris-clipped intrao...Reenclavation of a partially disenclavated retropupillary iris-clipped intrao...
Reenclavation of a partially disenclavated retropupillary iris-clipped intrao...
Alvina Pauline Santiago, MD
 
Spontaneous consecutive exotropia, 2022.pdf
Spontaneous consecutive exotropia, 2022.pdfSpontaneous consecutive exotropia, 2022.pdf
Spontaneous consecutive exotropia, 2022.pdf
Alvina Pauline Santiago, MD
 
A meta-analysis on the use of atropine for myopia control.pdf
A meta-analysis on the use of atropine for myopia control.pdfA meta-analysis on the use of atropine for myopia control.pdf
A meta-analysis on the use of atropine for myopia control.pdf
Alvina Pauline Santiago, MD
 
Social Media and Your Practice, Philippine Academy of Ophthalmology 2022
Social Media and Your Practice, Philippine Academy of Ophthalmology 2022Social Media and Your Practice, Philippine Academy of Ophthalmology 2022
Social Media and Your Practice, Philippine Academy of Ophthalmology 2022
Alvina Pauline Santiago, MD
 
Social Media and the Ophthalmologist, August 2023
Social Media and the Ophthalmologist, August 2023Social Media and the Ophthalmologist, August 2023
Social Media and the Ophthalmologist, August 2023
Alvina Pauline Santiago, MD
 
Creating a Social Media Policy for the Philippine Academy of Ophthalmology.pdf
Creating a Social Media Policy for the Philippine Academy of Ophthalmology.pdfCreating a Social Media Policy for the Philippine Academy of Ophthalmology.pdf
Creating a Social Media Policy for the Philippine Academy of Ophthalmology.pdf
Alvina Pauline Santiago, MD
 
Strabismus Surgeries for Cranial Nerve Palsies
Strabismus Surgeries for Cranial Nerve PalsiesStrabismus Surgeries for Cranial Nerve Palsies
Strabismus Surgeries for Cranial Nerve Palsies
Alvina Pauline Santiago, MD
 
Pre- and Perioperative Measures in Rubella Cataract Management: The Departmen...
Pre- and Perioperative Measures in Rubella Cataract Management: The Departmen...Pre- and Perioperative Measures in Rubella Cataract Management: The Departmen...
Pre- and Perioperative Measures in Rubella Cataract Management: The Departmen...
Alvina Pauline Santiago, MD
 
E-poster on Reenclavation of a partially disenclavated retropupillary iris-cl...
E-poster on Reenclavation of a partially disenclavated retropupillary iris-cl...E-poster on Reenclavation of a partially disenclavated retropupillary iris-cl...
E-poster on Reenclavation of a partially disenclavated retropupillary iris-cl...
Alvina Pauline Santiago, MD
 
Beyond the screen: caring for our eyes: 2022 kids pandemic eyes for XS Nuvali...
Beyond the screen: caring for our eyes: 2022 kids pandemic eyes for XS Nuvali...Beyond the screen: caring for our eyes: 2022 kids pandemic eyes for XS Nuvali...
Beyond the screen: caring for our eyes: 2022 kids pandemic eyes for XS Nuvali...
Alvina Pauline Santiago, MD
 
2021 kids pandemic eyes: keeping them healthy
2021 kids pandemic eyes: keeping them healthy2021 kids pandemic eyes: keeping them healthy
2021 kids pandemic eyes: keeping them healthy
Alvina Pauline Santiago, MD
 
Binocular Vision and Ocular Motility
Binocular Vision and Ocular MotilityBinocular Vision and Ocular Motility
Binocular Vision and Ocular Motility
Alvina Pauline Santiago, MD
 
2020 digital eye strain for tmc eyetv
2020 digital eye strain for tmc eyetv2020 digital eye strain for tmc eyetv
2020 digital eye strain for tmc eyetv
Alvina Pauline Santiago, MD
 
Principles of strabismus surgery part 3 of 3
Principles of strabismus surgery part 3 of 3Principles of strabismus surgery part 3 of 3
Principles of strabismus surgery part 3 of 3
Alvina Pauline Santiago, MD
 
Principles of strabismus surgery part 2 of 3
Principles of strabismus surgery part 2 of 3Principles of strabismus surgery part 2 of 3
Principles of strabismus surgery part 2 of 3
Alvina Pauline Santiago, MD
 
Principles of strabismus surgery part 1 of 3
Principles of strabismus surgery part 1 of 3Principles of strabismus surgery part 1 of 3
Principles of strabismus surgery part 1 of 3
Alvina Pauline Santiago, MD
 
2019 Pgh Basic Motility Exam
2019 Pgh Basic Motility Exam2019 Pgh Basic Motility Exam
2019 Pgh Basic Motility Exam
Alvina Pauline Santiago, MD
 
Myopia: Risk Factor for Ocular Morbidity and Permanent Visual Loss
Myopia: Risk Factor for Ocular Morbidity and Permanent Visual LossMyopia: Risk Factor for Ocular Morbidity and Permanent Visual Loss
Myopia: Risk Factor for Ocular Morbidity and Permanent Visual Loss
Alvina Pauline Santiago, MD
 
2019 vision screen peds postgrad
2019 vision screen peds postgrad2019 vision screen peds postgrad
2019 vision screen peds postgrad
Alvina Pauline Santiago, MD
 

More from Alvina Pauline Santiago, MD (20)

Ocular hypotony following reenclavation of a partially dislocated (disenclava...
Ocular hypotony following reenclavation of a partially dislocated (disenclava...Ocular hypotony following reenclavation of a partially dislocated (disenclava...
Ocular hypotony following reenclavation of a partially dislocated (disenclava...
 
Reenclavation of a partially disenclavated retropupillary iris-clipped intrao...
Reenclavation of a partially disenclavated retropupillary iris-clipped intrao...Reenclavation of a partially disenclavated retropupillary iris-clipped intrao...
Reenclavation of a partially disenclavated retropupillary iris-clipped intrao...
 
Spontaneous consecutive exotropia, 2022.pdf
Spontaneous consecutive exotropia, 2022.pdfSpontaneous consecutive exotropia, 2022.pdf
Spontaneous consecutive exotropia, 2022.pdf
 
A meta-analysis on the use of atropine for myopia control.pdf
A meta-analysis on the use of atropine for myopia control.pdfA meta-analysis on the use of atropine for myopia control.pdf
A meta-analysis on the use of atropine for myopia control.pdf
 
Social Media and Your Practice, Philippine Academy of Ophthalmology 2022
Social Media and Your Practice, Philippine Academy of Ophthalmology 2022Social Media and Your Practice, Philippine Academy of Ophthalmology 2022
Social Media and Your Practice, Philippine Academy of Ophthalmology 2022
 
Social Media and the Ophthalmologist, August 2023
Social Media and the Ophthalmologist, August 2023Social Media and the Ophthalmologist, August 2023
Social Media and the Ophthalmologist, August 2023
 
Creating a Social Media Policy for the Philippine Academy of Ophthalmology.pdf
Creating a Social Media Policy for the Philippine Academy of Ophthalmology.pdfCreating a Social Media Policy for the Philippine Academy of Ophthalmology.pdf
Creating a Social Media Policy for the Philippine Academy of Ophthalmology.pdf
 
Strabismus Surgeries for Cranial Nerve Palsies
Strabismus Surgeries for Cranial Nerve PalsiesStrabismus Surgeries for Cranial Nerve Palsies
Strabismus Surgeries for Cranial Nerve Palsies
 
Pre- and Perioperative Measures in Rubella Cataract Management: The Departmen...
Pre- and Perioperative Measures in Rubella Cataract Management: The Departmen...Pre- and Perioperative Measures in Rubella Cataract Management: The Departmen...
Pre- and Perioperative Measures in Rubella Cataract Management: The Departmen...
 
E-poster on Reenclavation of a partially disenclavated retropupillary iris-cl...
E-poster on Reenclavation of a partially disenclavated retropupillary iris-cl...E-poster on Reenclavation of a partially disenclavated retropupillary iris-cl...
E-poster on Reenclavation of a partially disenclavated retropupillary iris-cl...
 
Beyond the screen: caring for our eyes: 2022 kids pandemic eyes for XS Nuvali...
Beyond the screen: caring for our eyes: 2022 kids pandemic eyes for XS Nuvali...Beyond the screen: caring for our eyes: 2022 kids pandemic eyes for XS Nuvali...
Beyond the screen: caring for our eyes: 2022 kids pandemic eyes for XS Nuvali...
 
2021 kids pandemic eyes: keeping them healthy
2021 kids pandemic eyes: keeping them healthy2021 kids pandemic eyes: keeping them healthy
2021 kids pandemic eyes: keeping them healthy
 
Binocular Vision and Ocular Motility
Binocular Vision and Ocular MotilityBinocular Vision and Ocular Motility
Binocular Vision and Ocular Motility
 
2020 digital eye strain for tmc eyetv
2020 digital eye strain for tmc eyetv2020 digital eye strain for tmc eyetv
2020 digital eye strain for tmc eyetv
 
Principles of strabismus surgery part 3 of 3
Principles of strabismus surgery part 3 of 3Principles of strabismus surgery part 3 of 3
Principles of strabismus surgery part 3 of 3
 
Principles of strabismus surgery part 2 of 3
Principles of strabismus surgery part 2 of 3Principles of strabismus surgery part 2 of 3
Principles of strabismus surgery part 2 of 3
 
Principles of strabismus surgery part 1 of 3
Principles of strabismus surgery part 1 of 3Principles of strabismus surgery part 1 of 3
Principles of strabismus surgery part 1 of 3
 
2019 Pgh Basic Motility Exam
2019 Pgh Basic Motility Exam2019 Pgh Basic Motility Exam
2019 Pgh Basic Motility Exam
 
Myopia: Risk Factor for Ocular Morbidity and Permanent Visual Loss
Myopia: Risk Factor for Ocular Morbidity and Permanent Visual LossMyopia: Risk Factor for Ocular Morbidity and Permanent Visual Loss
Myopia: Risk Factor for Ocular Morbidity and Permanent Visual Loss
 
2019 vision screen peds postgrad
2019 vision screen peds postgrad2019 vision screen peds postgrad
2019 vision screen peds postgrad
 

Recently uploaded

Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 

Recently uploaded (20)

Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 

2018 pedig amblyopia v1

  • 1. Amblyopia Treatment Studies Pediatric Eye Disease Investigator Group 2002-2018 (Based on Publications as of September 2018) Alvina Pauline D. Santiago, MD September 2018 #PEDIG (c) APSantiago 2018
  • 3. Amblyopia Definition Gunter K von Noorden • Unilateral or bilateral decrease in VA • caused by pattern vision deprivation (lack of adequate vision stimulation) or abnormal binocular interaction • no cause can be detected by physical examination • reversible by therapeutic measures http://www.ascrs.org vonNoorden GK. Amblyopia. A Multidisciplinary Approach. Proctor Lecture. IOVS; 1985; 26: 1704-16 #PEDIG (c) APSantiago 2018
  • 4. Definition of Terms: PEDIG •Amblyopia • Mild: 20/25 to < 20/40 • Moderate: 20/40 to 20/100 ATS-1, -8, -9 20/40 to 20/80 ATS-2B, -4, 10 • Severe: 20/100 to 20/400 ATS-2A #PEDIG (c) APSantiago 2018
  • 5. Amblyopia Treatment Study-1 (ATS-01) Atropine vs part-time patch, moderate amblyopia I. Arch Ophthalmol 2002: 120(3) 268-278 II. Arch Ophthalmol 2002: 120 (3) 281-287 III. Arch Ophthalmol 2003: 121 (11): 1625-32 IV. Arch Ophthalmol 2005: 123 (2): 149-157 V. J AAPOS 2005: 9 (6): 542-545 VI. Arch Ophthalmol 2008: 1039-1044 VII. JAMA Ophthalmol. 2014 July ; 132(7): 799–805 VIII. Arch Ophthalmol 2002: 120(3) 268-278 #PEDIG (c) APSantiago 2018
  • 6. Amblyopia Treatment Study-1 (ATS-01) Atropine vs part-time patch, moderate amblyopia  3-7 years  >/= 3 lines 79%P, 74%A  Atropine better acceptability  Strabismic=anisometropic amblyopia  2 yr follow-up, after 6 months treatment, both 2 lines behind  Same rates of deterioration & improvement  New strabismus resolved with cessation of treatment (18%P, 16%A) #PEDIG (c) APSantiago 2018
  • 7. 10 & 15 years follow-up • improvement maintained • residual amblyopia common http://www.ibeta.com Arch Ophthalmol 2008: 1039-1044; JAMA Ophthalmol. 2014 July ; 132(7): 799–805 Amblyopia Treatment Study-1 (ATS-01) Atropine vs part-time patch, moderate amblyopia http://logopond.com/ #PEDIG (c) APSantiago 2018
  • 8. Amblyopia Treatment Study-2 (ATS-2) (6h vs full; 2h vs 6h) • I. Ophthalmology 2003: 110(11) 2075-2087 • II. Arch Ophthalmol 2003: 121 (5) 603-611 • III. J AAPOS 2004: 8(5): 420-428 https://upload.wikimedia.org https://www.hosteurope.de https://blog.logos.com #PEDIG (c) APSantiago 2018
  • 9. Amblyopia Treatment Study-2A (ATS-2A) Patch 6 hrs vs full time, severe amblyopia • Full time: all waking hrs minus 1 hour off • Severe amblyopia: 20/100-20/400 • Age 3-7 years • After 4 months • 4.8 lines in 6 hrs group; vs 4.7 in full time http://oceansignal.com http://oceansignal.com Ophthalmology 2003: 110(11) 2075-2087 #PEDIG (c) APSantiago 2018
  • 10. Amblyopia Treatment Study-2B (ATS-2B) Patch 2 hrs (minimal time) vs 6 hrs (part time) for Moderate amblyopia • moderate: 20/40-20/80 • ages 3-7 years • At 4 months: 2.4 lines in both groups with 1 hr of near visual activity https://www.hosteurope.de https://upload.wikimedia.org http://oceansignal.com Arch Ophthalmol 2003: 121 (5) 603-611 #PEDIG (c) APSantiago 2018
  • 11. Amblyopia Treatment Study-2C (ATS-2C) Recurrence after cessation of patching / Atropine • younger than age 8 • 3 months of amblyopia treatment • Recurrence same • 24% of patched patients; • 21% of atropinized • 1/4 experience recurrence within 1st year of cessation • RCT for weaning vs. no-weaning J AAPOS 2004: 8(5): 420-428 #PEDIG (c) APSantiago 2018
  • 12. Amblyopia Treatment Study-3 (ATS-3) 7 to < 18: spectacles vs atropine/patch • Arch Ophthalmol 2005: 123: 437-477 (Control) • Am J Ophthalmol 2004: 137: 581-583 (10-18yrs) • Arch Ophthalmol 2007: 125: 655-659 http://cdn4.teen.com http://cdn4.teen.com #PEDIG (c) APSantiago 2018
  • 13. Amblyopia Treatment Study-3 (ATS-3) 7 to < 18: spectacles vs atropine/patch • ages 7-17 years • 20/40-20/400 • Given optimal optical correction then randomized • Tx: glasses, patch plus near activity, atropine • No Tx: glasses alone http://cdn4.teen.com Arch Ophthalmol 2005: 123: 437-477 (Control) Am J Ophthalmol 2004: 137: 581-583 (10-18yrs) Arch Ophthalmol 2007: 125: 655-659 #PEDIG (c) APSantiago 2018
  • 14. Amblyopia Treatment Study-3 (ATS-3) 7 to < 18: spectacles vs atropine/patch • Responders: improved > 10 letters / 2 lines • Improves with glasses alone in 25% • Most patients left with residual VA deficit • Ages 7-12: tx improved amblyopia even if previously treated • Ages 13-17: tx improved if no previous tx for amblyopia • Unknown: if treatment results robust http://cdn4.teen.com Arch Ophthalmol 2005: 123: 437-477 (Control) Am J Ophthalmol 2004: 137: 581-583 (10-18yrs) Arch Ophthalmol 2007: 125: 655-659 #PEDIG (c) APSantiago 2018
  • 15. Amblyopia Treatment Study-4 (ATS-4) Atropine weekend vs daily; moderate amblyopia • 20/40-20/80 • ages 3-7 years • Similar results with weekend atropine vs daily atropine • 2.3 lines in both groups https://thejobshop.files.wordpress.com Ophthalmology 2004: 111: 2076-2085 #PEDIG (c) APSantiago 2018
  • 16. Amblyopia Treatment Study-5 (ATS-5) 3 to < 7y, spectacles alone • amblyopia improved with glasses by > 2 lines in 77% • amblyopia resolved in 27% with glasses alone • 3 line improvement average • Lessen the burden of amblyopia therapy Ophthalmology 2006: 113 (6) 895-903. #PEDIG (c) APSantiago 2018
  • 17. Amblyopia Treatment Study-5 (ATS-5) spectacles first then patch 2 hrs vs spectacles, 20/40-20/400 o Strabismic &anisometropic amblyopia o 2 hrs (1 hr near activity) + specs vs. specs alone • At 5 wks: 1.1 lines improvement for treated; 0.5 lines for specs alone • Any visit average: 2.2 lines treated; 1.1 lines specs • After glasses, 2 hrs patching (with 1 hr near activity) improves moderate to severe amblyopia https://t2.ftcdn.net ✚ http://cdn4.teen.com #PEDIG (c) APSantiago 2018 http://cdn4.teen.com
  • 18. Amblyopia Treatment Study-6 (ATS-6) 3 to <7, patch 2 hrs with near vs far activities after spectacles • Pilot: 4 wks: suggestion of greater improvement in amblyopic eye with near activities prescribed • 2.6 lines near; 1.6 lines far (p=0.07) http://www.adventuresetup.com http://glacialblog.com J AAPOS 2005: 9: 129-136 #PEDIG (c) APSantiago 2018
  • 19. Amblyopia Treatment Study-6 (ATS-6) 3 to <7, patch 2 hrs with near vs far activities after spectacles (VA 20/40 to 20/400) • At 8 wks: improvement in amblyopic eye • Distance activity: 2.6 lines • Near activity: 2.5 lines 2.6 lines near; 1.6 lines far (p=0.07) • Similar for both groups, even at 2, 5, 17 wks. http://s7.photobucket.com Ophthalmology 2008; 115: 2071-78 #PEDIG (c) APSantiago 2018
  • 20. Amblyopia Treatment Study-6 (ATS-6) 3 to <7, patch 2 hrs with near vs far activities after spectacles (VA 20/40 to 20/400) • 3.6 lines improvement in severe amblyopic group • Adding near activities did not improve VA outcome in anisometropic, strabismic, combined amblyopia with 2 hrs of daily patching • Severe amblyopia can respond even to 2 hrs of daily patching http://www.getbettergradesnow.com Ophthalmology 2008; 115: 2071-78 #PEDIG (c) APSantiago 2018
  • 21. Amblyopia Treatment Study-7 (ATS-7) Bilateral refractive amblyopia 20/40-20/400; specs x 1 yr (Response to treatment of previously untreated presumed bilateral refractive amblyopia) • less than 10 years old • Hypermetropia > 4.0D; • astigmatism > 2.0D • Eyeglasses alone improves binocular VA to 20/25 or better within 1 year http://cdn4.teen.com Am J Ophthalmol 2007: 144: 487-496 #PEDIG (c) APSantiago 2018
  • 22. • Age 7-12; moderate amblyopia 20/40-20/100 • similar degrees of improvement • About 1 in 5 achieved VA of 20/25 or better in the amblyopic eye. • Atropine and patching achieved similar results among older children with unilateral amblyopia Amblyopia Treatment Study-9 (ATS-9) (7 to <13, ATS-1: weekend atropine vs. patch 2hours http://dissurat.net https://t2.ftcdn.net Arch Ophthalmol. 2008;126(12):1634-1642 #PEDIG (c) APSantiago 2018
  • 23. Amblyopia Treatment Study-10 (ATS-10) Bangerter filters vs. patching • moderate amblyopia 20/40-20/80; 3-<10y. • At 24 wks, 1.9 lines improvement with Bangerter, vs.2.3 lines in patching group • Average difference in vision improvement between Bangerter filters and patching was less than half a line • ower burden of treatment on the child and family, Bangerter filter treatment is a reasonable option to consider for initial treatment of moderate amblyopia. Ophthalmology 2010;117:998-1004. | #PEDIG (c) APSantiago 2018 23
  • 24. ATS 13: An Observational Study of Optical Correction for Strabismic & Combined Strabismic Anisometropic Amblyopia in Children 3 to < 7 years old • VA after 18 weeks improved mean of 2.6 lines • 75% > 2 lines, 54% > 3 lines • Resolution of amblyopia in 32% • Greater in Strabismic Amblyopia alone (3.2 vs 2.3 lines) • VA improved regardless of whether alignment better • Optical treatment alone results in clinically meaningful improvement; • may consider as primary sole initial treatment Ophthalmology 2012; 119: 150-158. Epub 2011 Sep 29. #PEDIG (c) APSantiago 2018
  • 25. ATS 15: Increasing patching for amblyopia study from 2 to 6 hours (3 to <8, 20/50 to 20/400) • When amblyopic eye VA stops improving with 2 hours of daily patching, increasing the daily patching dosage to 6 hours results in more improvement in VA after 10 weeks compared with continuing 2 hours daily. Pediatric Eye Disease Investigator Group. A randomized trial of increasing patching for amblyopia. Ophthalmology 2013 Nov;120(11):2270-7. Epub 2013 Jun 4 #PEDIG (c) APSantiago 2018
  • 26. Amblyopia Treatment Study-17 (ATS- 17) Levodopa for Residual Amblyopia • 7-12y, 20/50 to 20/400 with patching • 139 children 7-12 years old • Strabismic &/or anisometropic amblyopia • Pilot showed improvement at 4 weeks • But study at 18 weeks: placebo = levodopa Ophthalmology. 2015 May;122(5):874-819 Repka MX, Kraker RT, Beck RW, et. al., Pediatric Eye Disease Investigator Group. Pilot study of levodopa dose as treatment for residual amblyopia in children aged 8 years to younger than 18 years. Arch Ophthalmol 2010;128(9):1215-7. #PEDIG (c) APSantiago 2018
  • 28. Amblyopia Treatment Study-18 (ATS-18) Binocular Computer Studies for Amblyopia Ended May 2016 • To compare the effectiveness of 1 hour/day of binocular game play 7 days per week (minimum of 4 days per week) with 2 hours/day of patching 7 days per week, in children 5 to <13 years of age (younger cohort), as a non-inferiority study. • To compare the effectiveness of 1 hour/day of binocular game play 7 days per week (minimum of 4 days per week) with 2 hours/day of patching 7 days per week, in children 13 to <17 years of age (older cohort), as a superiority study. #PEDIG (c) APSantiago 2018
  • 29. Amblyopia Treatment Study-18 (ATS-18) Binocular iPAD game vs patching (5-12) • Non inferiority RCT • 16 wk trial • iPAD improved 1.05 lines vs patching 1.35 lines • primary noninferiority analysis was indeterminate • a post hoc analysis suggested that VA improvement with iPad not as good as with 2 hours of prescribed daily patching. Holmes et al … PEDIG. Effect of a binocular iPad game versus part-time patching in children aged 5 to 12 with amblyopia: a randomized clinical trial. JAMA Ophthalmol 2016;134(12) #PEDIG (c) APSantiago 2018
  • 30. Amblyopia Treatment Study-18 (ATS-18) Binocular iPAD game vs patching (13 to <17) • Amblyopia 20/40 to 20/200 • 16 wks of iPAD 1 h game or patching 2h/day • 3.5 letters in iPAD group vs. 6.5 letters in patching group • Even in the iPAD group, only 13% of patients completed >75% of prescribed treatment • PATCHING still better, iPAD possibly worse • Compliance vs lack of treatment effect? Manh VM, Holmes JM, Lazar EL, et al and Pediatric Eye Disease Investigator Group. A Randomized Trial Of A Binocular iPad Game Versus Part-Time Patching In Children 13 To 16 Years Of Age With Amblyopia. Am J Ophthalmol 2018;186:104-15. #PEDIG (c) APSantiago 2018
  • 32. Non PEDIG RCTs https://www.aao.org • 3-8 y, 20/40 to 20/100 • Glasses x 12 wks, no improvement • Occluded 50% x 4h vs Patching 2h • Not inferior to patching • Alternative for treatment #PEDIG (c) APSantiago 2018
  • 33. Amblyopia Treatment Study-19 (ATS-19) Excimer Laser Surgery for Anisometropic Amblyopia • Upcoming • To compare the efficacy and safety of surgical treatment (PRK) versus non-surgical treatment of anisometropic amblyopia in children who have failed conventional treatment due to non- compliance or non-response. #PEDIG (c) APSantiago 2018
  • 34. Amblyopia Treatment Study-20 (ATS-20) Binocular Dig Rush Game for Amblyopia • Recruiting • 1 hour/day of binocular game play 5 days per week plus spectacle correction vs. spectacle correction only • for treatment of amblyopia • children 4 to <13 years of age. #PEDIG (c) APSantiago 2018 https://www.ophth.wisc.edu/blog/2018/02/12/binocular-dig- rush-game-treatment-amblyopia/
  • 35. Recap: Lessons learned from PEDIG 1. Atropine = patching • 3-7 years old, 20-40 to 20/100 • Anisometropic and strabismic amblyopia • Long-term follow-up 10y and 15y same • New strabismus can develop in either by 2 years 16-18%, • Resolved at cessation of therapy • Residual amblyopia common • 7-12y, 20/40 to 20/100 • 1 in 5 achieved > 20/25 #PEDIG (c) APSantiago 2018
  • 36. Recap: Lessons learned from PEDIG 2. 6 hours = full time • 3-7 years old • Severe amblyopia 20/100-20/400 3. 2 = 6 hours • 3-7 years old • Moderate amblyopia 20/40 to 20/80 #PEDIG (c) APSantiago 2018
  • 37. Recap: Lessons learned from PEDIG 4. Amblyopia improves with glasses alone. • 20/40 to 20/400, 7-17y (25%) • 3 to <7, 20/40 to 20/400 • Resolved in 27% • Improved in 77% • Better improvement in strabismic than combined strabismic and amblyopic amblyopia • Less than 10y, 20/40 to 20/400 • Bilateral refractive amblyopia VA > 20/25 in a year AP Santiago MD 2017 #PEDIG (c) APSantiago 2018
  • 38. Recap: Lessons learned from PEDIG 5. Atropine and/or patching can be added after glasses. • Moderate to severe amblyopia 20/40 to 20/400, 7 to <18 6. Add patching after glasses given time to work. • Moderate to severe amblyopia: 20/40 to 20/400 • 3 to <7y, 2h patch (1 hr near) • 7-12 even if previously treated • 13 to <18 if no previous treatment #PEDIG (c) APSantiago 2018
  • 39. Recap: Lessons learned from PEDIG 7. Daily = weekly atropine • 3-7 years • Moderate amblyopia: 20/40 to 20/80 8. Near = Far • 3-7 years • moderate to severe amblyopia: 20/40 to 20/400 AP Santiago MD 2017 #PEDIG (c) APSantiago 2018
  • 40. Lessons learned from PEDIG Studies 9. Severe amblyopia can improve even with 2 h of patching • 3-7 years, 20/40 to 20/400 10.Bangerter filter a reasonable option. • 3 to <10, 20/40 to 20/80 • Not better than patching • More acceptable 11.Patching 2h/d better than binocular iPAD • 5-<13, 13 to <17 • 20/40 to 20/200 #PEDIG (c) APSantiago 2018
  • 41. Lessons learned from PEDIG Studies 12. Intensive final push with atropine and patch not effective. 13.Levodopa same as placebo. • 8-17y, already on patching 14.6h >2h: Increasing 2 to 6 hours can improve amblyopia • 3 to <8m 20/50 to 20/400 • if plateau with 2 hours reached 15.Plano lenses don’t work. 16.Standardizing vision therapy unsuccessful. #PEDIG (c) APSantiago 2018
  • 42. What the future holds • Laser refractive correction as a viable option for anisometropic amblyopia • Others options • Virtual reality games • Smart glasses • Dichoptic movie viewing AP Santiago MD 2017 #PEDIG (c) APSantiago 2018
  • 43. Virtual Reality Games for Amblyopia ❖ 0:33 The Oculus Rift ❖ 0.38 – 1:29 How it Works https://www.youtube.com/watch?v=KumScsJ0xNQ #PEDIG (c) APSantiago 2018
  • 44. Amblyopia Glasses VIDI SMART GLASSES AMBLYZ AMBLYOPIA GLASSES http://eyepatch.com.au/product/Vidi-Smart-Glasses https://www.aao.org #PEDIG (c) APSantiago 2018
  • 45. Every closed eye is not sleeping, and every open eye is not seeing. -- Bill Cosby #PEDIG(c) APSantiago 2018